|
|
| Biotech Submits NDA After Risk-Based Mock Inspection | An emerging biotech company recently took a preventative approach to mitigate risks, identify potential concerns before an FDA inspection, and submit their NDA. See how these proactive measures accurately addressed gaps within its application and led to a successful submission. |
|
|
|
|
By Pankaj Singh, Global Market Insights | Here's an overview of advancements in technology and industry built around biopharmaceutical supply chain and logistics, including packaging and temperature controls. |
|
|
|
| Key Considerations When Selecting Packaging Components | Article | By Abigail Hisler, West Pharmaceutical Services, Inc. | Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks. |
|
|
|
|
|
|
|
|
|
.png){kind=logo}
